Annual CFF
$150.71 M
+$92.60 M+159.33%
30 April 2024
Summary:
KalVista Pharmaceuticals annual cash flow from financing activities is currently $150.71 million, with the most recent change of +$92.60 million (+159.33%) on 30 April 2024. During the last 3 years, it has fallen by -$61.40 million (-28.95%). KALV annual CFF is now -28.95% below its all-time high of $212.12 million, reached on 30 April 2021.KALV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$3.00 M
-$147.10 M-98.00%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly cash flow from financing activities is currently $3.00 million, with the most recent change of -$147.10 million (-98.00%) on 31 July 2024. Over the past year, it has increased by +$2.87 million (+2243.75%). KALV quarterly CFF is now -98.57% below its all-time high of $210.31 million, reached on 30 April 2021.KALV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$153.51 M
+$2.80 M+1.86%
31 July 2024
Summary:
KalVista Pharmaceuticals TTM cash flow from financing activities is currently $153.51 million, with the most recent change of +$2.80 million (+1.86%) on 31 July 2024. Over the past year, it has increased by +$95.40 million (+164.16%). KALV TTM CFF is now -27.82% below its all-time high of $212.68 million, reached on 31 October 2021.KALV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +159.3% | +2243.8% | +164.2% |
| 3 y3 years | -28.9% | +4661.9% | -27.8% |
| 5 y5 years | +71.4% | +2073.9% | +1206.6% |
KALV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.9% | +9432.8% | -98.0% | +9190.9% | -27.8% | >+9999.0% |
| 5 y | 5 years | -28.9% | +9432.8% | -98.6% | +9190.9% | -27.8% | >+9999.0% |
| alltime | all time | -28.9% | >+9999.0% | -98.6% | +166.7% | -27.8% | +3388.6% |
KalVista Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $3.00 M(-98.0%) | $153.51 M(+1.9%) |
| Apr 2024 | $150.71 M(+159.3%) | $150.10 M(>+9900.0%) | $150.71 M(>+9900.0%) |
| Jan 2024 | - | $284.00 K(+121.9%) | $583.00 K(-99.0%) |
| Oct 2023 | - | $128.00 K(-37.3%) | $58.11 M(-0.1%) |
| July 2023 | - | $204.00 K(-718.2%) | $58.15 M(+0.1%) |
| Apr 2023 | $58.12 M(+3575.9%) | -$33.00 K(-100.1%) | $58.12 M(-0.3%) |
| Jan 2023 | - | $57.81 M(>+9900.0%) | $58.29 M(+4577.9%) |
| Oct 2022 | - | $168.00 K(0.0%) | $1.25 M(+9.2%) |
| July 2022 | - | $168.00 K(+21.7%) | $1.14 M(-27.8%) |
| Apr 2022 | - | $138.00 K(-82.1%) | $1.58 M(-99.3%) |
| Apr 2022 | $1.58 M(-99.3%) | - | - |
| Jan 2022 | - | $772.00 K(+1125.4%) | $211.75 M(-0.4%) |
| Oct 2021 | - | $63.00 K(-89.6%) | $212.68 M(+0.0%) |
| July 2021 | - | $608.00 K(-99.7%) | $212.68 M(+0.3%) |
| Apr 2021 | $212.12 M(+1731.1%) | $210.31 M(>+9900.0%) | $212.12 M(>+9900.0%) |
| Jan 2021 | - | $1.70 M(+2738.3%) | $1.81 M(+1090.8%) |
| Oct 2020 | - | $60.00 K(+30.4%) | $152.00 K(-33.9%) |
| July 2020 | - | $46.00 K(+4500.0%) | $230.00 K(-98.0%) |
| Apr 2020 | $11.58 M(-86.8%) | $1000.00(-97.8%) | $11.58 M(-1.3%) |
| Jan 2020 | - | $45.00 K(-67.4%) | $11.74 M(-0.1%) |
| Oct 2019 | - | $138.00 K(-98.8%) | $11.75 M(-87.6%) |
| July 2019 | - | $11.40 M(+7254.8%) | $94.39 M(+7.3%) |
| Apr 2019 | $87.94 M | $155.00 K(+176.8%) | $87.94 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | $56.00 K(-99.9%) | $87.78 M(+0.1%) |
| Oct 2018 | - | $82.78 M(+1573.1%) | $87.67 M(+529.2%) |
| July 2018 | - | $4.95 M(<-9900.0%) | $13.93 M(+55.1%) |
| Apr 2018 | $8.99 M(>+9900.0%) | -$13.00 K(-75.0%) | $8.99 M(-0.1%) |
| Jan 2018 | - | -$52.00 K(-100.6%) | $9.00 M(-0.6%) |
| Oct 2017 | - | $9.05 M(>+9900.0%) | $9.05 M(>+9900.0%) |
| July 2017 | - | $0.00(-100.0%) | $5000.00(-100.1%) |
| Apr 2017 | $2000.00(-100.0%) | - | - |
| Sept 2016 | - | $5000.00(-100.1%) | -$4.49 M(-3.9%) |
| June 2016 | - | -$4.50 M(<-9900.0%) | -$4.67 M(-106.8%) |
| Apr 2016 | $33.00 M(-54.2%) | - | - |
| Mar 2016 | - | $0.00(-100.0%) | $68.55 M(-4.9%) |
| Dec 2015 | $72.06 M(+731.9%) | $6000.00(-103.4%) | $72.06 M(+1.4%) |
| Sept 2015 | - | -$176.00 K(-100.3%) | $71.04 M(-7.3%) |
| June 2015 | - | $68.72 M(+1856.2%) | $76.60 M(+883.2%) |
| Apr 2015 | $8.66 M(+56.7%) | - | - |
| Mar 2015 | - | $3.51 M(-446.1%) | $7.79 M(+40.9%) |
| Dec 2014 | $5.53 M(-13.8%) | -$1.01 M(-118.9%) | $5.53 M(-15.5%) |
| Sept 2014 | - | $5.38 M(-6283.9%) | $6.54 M(+462.6%) |
| June 2014 | - | -$87.00 K(-107.0%) | $1.16 M(-7.0%) |
| Mar 2014 | - | $1.25 M | $1.25 M |
| Dec 2013 | $6.42 M(+15.3%) | - | - |
| Dec 2012 | $5.56 M | - | - |
FAQ
- What is KalVista Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual CFF year-on-year change?
- What is KalVista Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly CFF year-on-year change?
- What is KalVista Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM CFF year-on-year change?
What is KalVista Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of KALV is $150.71 M
What is the all time high annual CFF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual cash flow from financing activities is $212.12 M
What is KalVista Pharmaceuticals annual CFF year-on-year change?
Over the past year, KALV annual cash flow from financing activities has changed by +$92.60 M (+159.33%)
What is KalVista Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of KALV is $3.00 M
What is the all time high quarterly CFF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly cash flow from financing activities is $210.31 M
What is KalVista Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, KALV quarterly cash flow from financing activities has changed by +$2.87 M (+2243.75%)
What is KalVista Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of KALV is $153.51 M
What is the all time high TTM CFF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM cash flow from financing activities is $212.68 M
What is KalVista Pharmaceuticals TTM CFF year-on-year change?
Over the past year, KALV TTM cash flow from financing activities has changed by +$95.40 M (+164.16%)